Accendra Health Inc. has announced its delisting from the New York Stock Exchange (NYSE) due to its common stock being deemed unsuitable for listing based on abnormally low selling price levels. This decision, effective November 16, 2026, marks a significant change for the company and reflects ongoing challenges in the medical equipment and supplies sector.

The NYSE informed Accendra that it would commence proceedings to delist the company’s common stock, citing Section 802.01D of the NYSE Listed Company Manual. The company has opted not to appeal this determination and will instead transition to the OTCQB market, where its stock will trade under the new ticker symbol "ACCH" starting November 17, 2026.

Background

Accendra Health Inc., incorporated in Virginia, operates in the wholesale medical, dental, and hospital equipment and supplies sector, classified under SIC 5047. The company trades on the New York Stock Exchange under the ticker ACH. As a large accelerated filer, Accendra is subject to stringent regulatory requirements, which it must now navigate as it shifts to the OTC market.

What the Filing Says

According to the recent SEC filing, "On November 16, 2026, Accendra Health, Inc. received notice from the New York Stock Exchange Regulation that it has suspended trading of the Company’s common stock and determined to commence proceedings to delist the Company’s common stock from the NYSE." The company’s stock was deemed unsuitable for listing due to low price levels.

Impact

This delisting may have significant implications for Accendra Health and its stakeholders, including shareholders, employees, and suppliers. Transitioning to the OTCQB market may limit the company’s visibility and liquidity, potentially affecting its ability to raise capital and attract investors. The broader industry may also feel the impact as Accendra’s situation highlights the challenges faced by companies in the medical equipment sector.

What's Next

The filing does not specify any further actions or plans following the transition to the OTCQB. However, the company will need to adapt its strategies to operate effectively in the new market environment.